BioNexus Gene Lab Statistics
Total Valuation
BGLC has a market cap or net worth of $7.38 million. The enterprise value is $4.72 million.
Important Dates
The last earnings date was Friday, November 14, 2025, after market close.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BGLC has 1.80 million shares outstanding. The number of shares has increased by 1.15% in one year.
| Current Share Class | 1.80M |
| Shares Outstanding | 1.80M |
| Shares Change (YoY) | +1.15% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 36.95% |
| Owned by Institutions (%) | 1.37% |
| Float | 1.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.78 |
| Forward PS | n/a |
| PB Ratio | 1.08 |
| P/TBV Ratio | 1.08 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.30, with a Debt / Equity ratio of 0.03.
| Current Ratio | 8.30 |
| Quick Ratio | 6.81 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -110.81 |
Financial Efficiency
Return on equity (ROE) is -28.35% and return on invested capital (ROIC) is -18.33%.
| Return on Equity (ROE) | -28.35% |
| Return on Assets (ROA) | -16.43% |
| Return on Invested Capital (ROIC) | -18.33% |
| Return on Capital Employed (ROCE) | -35.24% |
| Revenue Per Employee | $315,500 |
| Profits Per Employee | -$76,560 |
| Employee Count | 30 |
| Asset Turnover | 1.02 |
| Inventory Turnover | 6.73 |
Taxes
| Income Tax | -73,713 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +28.04% in the last 52 weeks. The beta is 2.21, so BGLC's price volatility has been higher than the market average.
| Beta (5Y) | 2.21 |
| 52-Week Price Change | +28.04% |
| 50-Day Moving Average | 5.01 |
| 200-Day Moving Average | 4.28 |
| Relative Strength Index (RSI) | 33.29 |
| Average Volume (20 Days) | 311,035 |
Short Selling Information
The latest short interest is 64,704, so 3.60% of the outstanding shares have been sold short.
| Short Interest | 64,704 |
| Short Previous Month | 15,556 |
| Short % of Shares Out | 3.60% |
| Short % of Float | 5.71% |
| Short Ratio (days to cover) | 0.37 |
Income Statement
In the last 12 months, BGLC had revenue of $9.47 million and -$2.30 million in losses. Loss per share was -$1.28.
| Revenue | 9.47M |
| Gross Profit | 1.40M |
| Operating Income | -2.45M |
| Pretax Income | -2.37M |
| Net Income | -2.30M |
| EBITDA | -2.33M |
| EBIT | -2.45M |
| Loss Per Share | -$1.28 |
Full Income StatementBalance Sheet
The company has $2.89 million in cash and $233,722 in debt, giving a net cash position of $2.66 million or $1.48 per share.
| Cash & Cash Equivalents | 2.89M |
| Total Debt | 233,722 |
| Net Cash | 2.66M |
| Net Cash Per Share | $1.48 |
| Equity (Book Value) | 6.82M |
| Book Value Per Share | 3.79 |
| Working Capital | 4.95M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$2.72 million and capital expenditures -$40,016, giving a free cash flow of -$2.76 million.
| Operating Cash Flow | -2.72M |
| Capital Expenditures | -40,016 |
| Free Cash Flow | -2.76M |
| FCF Per Share | -$1.54 |
Full Cash Flow StatementMargins
Gross margin is 14.77%, with operating and profit margins of -25.85% and -24.27%.
| Gross Margin | 14.77% |
| Operating Margin | -25.85% |
| Pretax Margin | -25.05% |
| Profit Margin | -24.27% |
| EBITDA Margin | -24.66% |
| EBIT Margin | -25.85% |
| FCF Margin | n/a |
Dividends & Yields
BGLC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.15% |
| Shareholder Yield | -1.15% |
| Earnings Yield | -31.11% |
| FCF Yield | -37.40% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 7, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Apr 7, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
BGLC has an Altman Z-Score of 5.1 and a Piotroski F-Score of 3.
| Altman Z-Score | 5.1 |
| Piotroski F-Score | 3 |